Kimberly Gavin

Title: Kimberly Gavin: Innovator in Replication Complex Genes

Introduction

Kimberly Gavin is a prominent inventor based in Cold Spring Harbor, NY (US). She has made significant contributions to the field of molecular biology, particularly in the study of replication complex genes. With a total of 2 patents, her work has implications for understanding and treating diseases associated with undesirable cell growth.

Latest Patents

Gavin's latest patents focus on the Origin of Replication Complex (ORC) genes. These patents include nucleic acids that encode ORC proteins and hybridization reagents, probes, and primers capable of hybridizing with ORC genes. The methods described in her patents involve screening chemical libraries for lead compounds that can serve as pharmacological agents useful in diagnosing or treating diseases linked to undesirable cell growth. An exemplary screening process involves forming a mixture that includes a recombinant ORC protein, a natural intracellular ORC protein binding target, and a candidate pharmacological agent. The mixture is incubated under specific conditions to detect the binding of the ORC protein to the binding target.

Career Highlights

Throughout her career, Kimberly Gavin has worked with esteemed institutions such as Cold Spring Harbor Laboratory and the University of California. Her research has been pivotal in advancing the understanding of replication processes at the molecular level.

Collaborations

Gavin has collaborated with notable scientists, including Bruce W. Stillman and Stephen P. Bell. These collaborations have further enriched her research and contributed to the scientific community's knowledge of replication complex genes.

Conclusion

Kimberly Gavin's innovative work in the field of replication complex genes has led to valuable patents that may aid in the diagnosis and treatment of diseases. Her contributions continue to influence molecular biology and pharmacological research.